This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Altus signs $25mm deal with Cystic Fibrosis Foundation; ends
26 Feb 2009
The Cystic Fibrosis Foundation Therapeutics Inc.--the technology transfer arm of the Cystic Fibrosis Foundation--is paying Altus Biologics (protein-based therapeutics, diagnostics, and industrial products) up to $25mm in development milestones and providing the company with access to its clinical research network, so that Altus may conclude the development of its TheraCLEC-Total pancreatic insufficiency drug.
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?